Post-approval studies (Phase 4)Study completedNCT01742299
What this trial is testing
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Who this might be right for
GIST and CML
Novartis Pharmaceuticals 155